REVIEW Beyond diabetes: saving lives with insulin in the ICU
|
|
- Rafe Farmer
- 5 years ago
- Views:
Transcription
1 (2002) 26, Suppl 3, S3 S8 ß 2002 Nature Publishing Group All rights reserved /02 $ REVIEW Beyond diabetes: saving lives with insulin in the ICU 1 * 1 Department of Intensive Care Medicine, University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium The risk of mortality or significant morbidity is high among long-stay intensive care unit (ICU) patients. Sepsis, polyneuropathy and multiple organ failure are prominent causes of mortality and morbidity in the ICU. Many ICU patients are hyperglycaemic, presumably reflecting an adaptive development of insulin resistance. We hypothesized that this hyperglycaemia predisposes patients to many of the typical ICU complications, prolonged intensive care dependence and excess mortality. Insulin therapy directed at establishing normoglycaemia was investigated in a series of 1548 ICU patients. An intensive treatment group received insulin infusion tailored to control blood glucose levels in the range mmol=l (80 110mg=dl), whereas the conventional treatment group only received insulin when glucose levels exceeded 11.1 mmol=l (200 mg=dl) and in that event were maintained in a target range of mmol=l ( mg=dl). Intensive management of blood glucose levels was reflected in a 43% reduction in intensive care mortality risk (P ¼ after correction for interim analyses) and a 34% reduction in hospital mortality (P ¼ 0.01). A reduced risk of infection was reflected in a 46% reduction in the risk of septicaemia (P ¼ 0.003) and a 35% reduction in the need for prolonged ( > 10 d) antibiotic therapy (P < 0.001). Regression analysis suggests that control of glucose levels, rather than insulin administration itself, was responsible for the clinical benefits observed. Use of insulin infusion to control glucose levels in ICU patients, at least in populations similar to those in our study, can be expected to achieve clinically welcome improvements in outcome. An algorithm is proposed for implementing this. Further data are needed to establish the applicability of this strategy to other patient groups in the ICU and in general hospital care. (2002) 26, Suppl 3, S3 S8. doi: =sj.ijo Keywords: intensive care unit; clinical outcome; hyperglycaemia; intensive treatment; mortality risk; algorithm; sepsis Introduction There is a pressing need to improve outcomes for long-stay patients in intensive care units (ICUs). Approximately 30% of patients in surgical ICUs require more than 5 days intensive care and, despite our best efforts, the risk of mortality or significant morbidity among these long-stay patients is at least 20%. 1 Outcomes would be expected to be even worse among ICU patients with diabetes. Of course, many ICU patients have grave underlying conditions or have undergone severe trauma or major surgery, evidenced by their very presence in the unit. Nevertheless, the nature of the complications frequently occurring in these patients suggests that there is scope for improvement. There is, for example, much interest in therapies aimed at reducing the risk of sepsis and, in particular, septic shock in the ICU patient. 2 Septic shock is the most common cause of death in the ICU, and accounts for more than deaths per year in the USA alone. 3 Sepsis is closely associated with a series of inflammatory and metabolic responses to infection that may contribute to the multiple organ failure also common in long-stay ICU patients. 2 Polyneuropathy and skeletal muscle wasting are common, and prolong the need for mechanical ventilation. 4 6 The causes of critical-illness polyneuropathy are unclear but its consequences are severe. As in many areas of medicine, management of critical illness has had its share of rising hopes and disappointments as magic bullets fail to reach their targets. 1,7 Those therapies that have shown promise can be costly and raise fresh ethical questions concerning fair distribution of resources. 8 *Correspondence:, Department of Intensive Care Medicine, University Hospital Gasthuisberg, University of Leuven, B-3000 Leuven, Belgium. greta.vandenberghe@med.kuleuven.ac.be Glucose and insulin as targets for intervention in the ICU It is well established that hyperglycaemia is common in critically-ill patients, even if there is no history of diabetes. 9 This reflects the development of insulin resistance, at receptor and postreceptor level, in liver and muscle. This may be
2 S4 Insulin use during intensive care an adaptive response to life-threatening illness, ensuring adequate supply of glucose to the brain, to erythrocytes and to injured tissues. However, the benefits of this response may be outweighed by detrimental effects in the longer term. There is evidence linking hyperglycaemia with worse outcome after stroke and brain injury and with larger infarct size after myocardial infarction (MI). 10,11 Prevention of excessive hyperglycaemia [maintaining a level below 12 mmol=l (215 mg=dl)] in the DIGAMI trial was associated with a significant improvement in survival of diabetes patients with acute MI. 12 As well as the presumably macrovascular effects of excessive hyperglycaemia, there is the possible effect at any wound site: even mildly elevated glucose levels have been found to be associated with increased morbidity and mortality after burns or surgery. Although there is no clear evidence for a causal relationship, effects on a range of systems including mitochondrial metabolic pathways, endothelial function and cardiac potassium channels may be involved A role of hyperglycaemia in promoting bacterial infections of wound tissues and the blood is also intuitive. There are suggestions, however, that some of the beneficial effects of interventions that achieve glycaemic control via insulin in critically ill patients may reflect independent actions of insulin, rather than normalization of hyperglycaemia per se. 13 Glucose-insulin-potassium (GIK) infusion has been shown to salvage myocardium, increase heart function and improve mortality in patients with MI, perhaps independently of circulating glucose concentrations. 16,17 The Leuven Study: intensive insulin therapy in critically-ill patients We investigated the value of insulin therapy directed at establishing strict normoglycaemia ( mmol=l or mg=dl) in a series of 1548 patients entering the ICU at Leuven University Hospital. 18 All patients admitted to the unit and receiving mechanical ventilation were eligible for entry: only 14 patients were excluded (moribund state, donot-resuscitate order in place, participation in other trial). The largest fraction (63%) of patients in the study had undergone cardiac surgery, with the remaining patients admitted for a range of noncardiac indications (Table 1). Patients were randomised to receive intensive (n ¼ 765) or conventional (n ¼ 783) therapy on entry to the ICU. Glucose levels were measured at 1 4 hourly intervals in undiluted arterial blood. Conventionally-treated patients received a continuous insulin infusion only if their blood glucose level exceeded 12 mmol=l (215 mg=dl). Patients in the conventional group receiving insulin infusion were to be maintained in a target range of mmol=l or mg=dl. In contrast, patients in the intensive-treatment group received insulin infusion if blood glucose exceeded 6.1 mmol=l (110 mg=dl), the infusion then being adjusted to Table 1 Patients entering the Leuven Study: key characteristics at baseline 18 Intensive Conventional treatment treatment (n ¼ 765) (n ¼ 783) Gender (M=F) 544= =226 Age (mean, y) Reason for ICU entry Cardiac surgery 477 (62%) 493 (63%) Neurologic disease, cerebral 33 (4%) 30 (4%) trauma, brain surgery Thoracic surgery and=or respiratory 66 (9%) 56 (7%) insufficiency Abdominal surgery or peritonitis 45 (6%) 58 (7%) Non-cardiac vascular surgery 30 (4%) 32 (4%) Multiple trauma or severe burns 33 (4%) 35 (4%) Transplantation 46 (6%) 44 (6%) Other 35 (5%) 35 (4%) History of diabetes 101 (13%) 103 (13%) Blood glucose level > 6.1 mmol=l (110 mg=dl) 557 (73%) 598 (76%) > 11.1 mmol=l (200 mg=dl) 81 (11%) 101 (13%) maintain normoglycaemia ( mmol=l or mg= dl) (Figure 1). All patients were fed continuously with 9 g intravenous glucose per hour on the admission day followed by parenteral or enteral feeding according to a standard schedule, progressively increasing the caloric intake up to an average of 25 Cal=kgBW=day after 7 days. On discharge from the ICU, conventional blood glucose control management was adopted with a target range of mmol=l ( mg=dl). Data from the 1548 patients in the study indicate that the algorithms for glucose control were appropriately applied: the conventional treatment group recording a mean morning blood glucose level of 8.5 mmol=l (153 mg=dl) and the intensive group 5.7 mmol=l or 103 mg=dl (P < ). Caloric intake was similar in the two groups, while insulin dose was as expected significantly higher in the intensive group. The primary outcome measure of the study was in-icu mortality, with in-hospital mortality as a secondary endpoint. Other secondary outcomes included morbidity measures such as bloodstream infections. The Leuven Study was planned to continue for 2 y but an interim analysis after 1 y revealed a significant reduction of in-icu mortality in the intensive treatment group, leading to the termination of the study on ethical grounds (Figure 2). During the study period, the mortality rate in the intensivetreatment group was 4.6%, vs 8.0% in the conventional group, representing a significant risk reduction of 43% (P ¼ after adjustment for the interim analyses). The mortality reduction was especially evident among long-stay ICU patients two thirds being non-cardiac surgery patients,
3 Insulin use during intensive care S5 Figure 1 Control of blood glucose levels during the study. Data are means s.e. 1 0 timepoint is the peak level during day 1 when insulin was started. Adapted from reference 19. Figure 2 Kaplan-Meier cumulative survival curves for patients in the intensive and conventional treatment groups. (a) Survival in the ICU; (b) Survival in the hospital. Differences were significant in each case (ICU mortality adjusted P ¼ 0.036; hospital mortality nominal P ¼ 0.01). Adapted from reference 18.
4 S6 Insulin use during intensive care Figure 4 Risk of critical illness polyneuropathy vs blood glucose level. Based on data from reference 18. Figure 3 Relative risk reductions for key measures of ICU morbidity. Based on data from reference 18. *P < 0.01; { P < Error bars: 95% confidence intervals. (intensive treatment, 10.6%; conventional treatment, 20.2%; P ¼ 0.005); indeed, mortality during the first 5 days of ICU stay was not different between treatment groups. The principal cause of death among patients in both groups was multiple organ failure (intensive group, 22/35 deaths; conventional group, 51=63 deaths). However, there was an evident reduction in the intensive-treatment group in the number of multiple organ failure deaths with a proven septic focus (8 vs 33 deaths). Morbidity analysis further showed that intensive treatment had reduced the risk of septicaemia by 46% (P ¼ 0.003), reflected also in a 35% reduction in risk of > 10 days antibiotic treatment (P < 0.001). This was accompanied by significant reductions in several other measures of criticalillness morbidity (Figure 3). Insulin or glucose? Our study showed that maintaining normoglycaemia with an insulin infusion dramatically reduces the risk of mortality in the ICU. But is the avoidance of hyperglycaemia, or the provision of insulin, the critical factor? We performed a multivariate logistic regression analysis on the effect of insulin dose and glucose level on risk of ICU mortality. 19 This indicated that both daily insulin dose and mean blood glucose level were independent positive predictors of in-icu mortality. Thus, a high glucose level increased the risk of death; meanwhile, a high daily insulin dose also increased the risk of death. This strongly suggests that the glucose level plays the critical role. The association of insulin dose with mortality risk does not however inevitably imply that insulin is itself hazardous. It is likely to reflect the severity of the hyperglycaemia and of the insulin resistance in the individuals requiring higher insulin doses. Further analysis of glucose levels and mortality risk indicates that, among long-stay ICU patients, those with better levels of control have the better prognosis, and vice versa, with no evident threshold for risk reduction above the normoglycaemic range (Figure 4). 18 Similarly, the risk of critical-illness polyneuropathy was continuously and linearly related to blood glucose level. Although suggestions have been made that insulin has anti-inflammatory effects, including an ability to suppress an impressive range of proinflammatory molecules, 20 the most compelling conclusion from the Leuven Study is that maintaining glucose levels in the normoglycaemic range is the key to reducing ICU mortality. Implications for critical care and an algorithm for insulin administration We have shown that strict maintenance of normoglycaemia during critical illness improves morbidity and mortality. We have also shown that this requires insulin administration in almost all ICU patients not only those with known diabetes. It is possible to develop a protocol for achieving and maintaining normoglycaemia in the ICU (Figure 5). As with any protocol, this algorithm alone does not guarantee improvement in quality of care or clinical outcome. 21 However, in the context of the treating physician s experience and intuition, this approach could be expected to realise significant reductions in ICU mortality and morbidity. It must be stressed, however, that insulin requirements in individual patients vary widely, depending on, for example, their insulin production reserves, their insulin sensitivity before and during critical illness, their caloric intake in the ICU and the severity and nature of their illness. The presence of infections or complications further affects insulin demand, as does the administration of concomitant medications such as corticosteroids. As a result, any algorithm can only be a recommendation that will have to be adapted to the individual condition of each patient. In particular, insulin dosing should be conducted with a degree of common sense: for example, a patient with a high glucose level on
5 Insulin use during intensive care insulin delivery. For example, if a patient is to be transported for investigation or surgery, all intravenous and enteral feeding is usually stopped. Insulin administration should therefore also be stopped, with glucose levels being checked before transport. A patient on full enteral tube feeding may have regular daily or twice-daily interruptions of feeding, in which case insulin should be stopped, or reduced to a low (0.5 IU=h) maintenance dose, during that time. When a patient is extubated prior to starting oral food intake, insulin dose will usually need to be reduced to match nutrient intake. When the patient is ready for discharge to an ordinary ward, insulin infusion can be stopped if the individual is near-normoglycaemic (11.1 mmol=l or 200 mg=dl or less) on low insulin doses (2 IU=h or less). If significant insulin doses are needed to maintain glucose levels below 11.1 mmol=l (200 mg=dl) it is likely that the patient has pre-existing diabetes and follow-up by an endocrinologist should be planned. An insulin regimen should be arranged with the consulting physician to ensure appropriate follow-up in the ordinary ward. S7 Figure 5 Suggested algorithm for achieving and maintaining normoglycaemia in the ICU. In all cases it is the responsibility of the treating physician, relying on experience and knowledge of the patient, to determine dosages and best treatment. Blood glucose levels are to be determined on site in undiluted arterial blood. Insulin, typically 50 IU soluble human insulin in 50 ml 0.9% saline, is administered by continuous infusion through a central venous line. BG, blood glucose. Based on data from reference 18. entry to the ICU (say, 400 mg=dl) should be treated with a relatively high starting insulin dose (say, 4 IU=h), whereas an individual with less severe hyperglycaemia would require a lower starting insulin dose. Subsequent insulin dose adjustments should be appropriate to previously-observed glucose levels, with the dose increment becoming smaller as the patient approaches the normoglycaemic range. Even after normoglycaemia is achieved, the need for monitoring of glucose levels and adjustment of insulin dose remains. In part, this anticipates an improvement in insulin sensitivity with time necessitating a reduction in insulin dose but also acknowledges that worsening infection, with increase in body temperature, increases insulin requirements. Special measures are necessary in patients at risk of acute renal failure. Regular substitution of urinary fluid loss is routinely performed in such patients to avoid fluctuations in intravascular filling status. In such cases, if the patient is receiving an insulin infusion the substitution solutions should also contain insulin appropriate to their glucose content, additional to the insulin infusion. Similarly, reduction or interruption of caloric intake should be accompanied by reduction or interruption of Significant improvements in clinical outcome in surgical ICU patients can be expected by improving their glycaemic status. Unresolved questions include the degree to which these data can be applied to other patient groups (eg medical ICU patients, children in the ICU, surgical patients in ordinary wards). It also remains to be established whether hyperglycaemia per se or the increased availability of insulin is responsible for the major benefits seen in our study. Acknowledgements Our study was performed at the University Hospital, Leuven, Belgium, with support from the Belgian Fund for Scientific Research, the Research Council of the University of Leuven, the Belgian Foundation for Congenital Heart Disease and an unrestricted research grant from Novo Nordisk. References 1 Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. New Engl J Med 1999; 341: Vincent J-L. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Crit Care 2001; 5(Suppl 2): S1 S5. 3 Parrillo JE. Pathogenetic mechanisms of septic shock. New Engl J Med 1993; 328: Zochodne DE, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987; 110: Leijten FSS, de Weerd AW. Critical illness polyneuropathy: a review of the literature, definition and pathophysiology. Clin Neurol Neurosurg 1994; 96:
6 S8 Insulin use during intensive care 6 Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24: Venn R. Sepsis, insulin and noninvasive ventilation. Crit Care 2002; 6: Hawryluck L, Crippen D. Ethics and critical care in the new millennium. Crit Care 2002; 6: Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15: Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001; 58: Capes SE, Hunt D, Malmberg K, Gerstine HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: Groeneveld ABJ, Beishuizen A, Visser FC. Insulin: a wonder drug in the critically ill? Crit Care 2002; 6: Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51: Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery 2000; 128: Diaz R, Paolasso EC, Piegas LS, Tajer CD, Moreno MG, Coravalan R, Isea JE, Romero G, on behalf of the ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98: Jonassen AK, Sack MN, Mjøs OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001; 89: Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. New Engl J Med 2001; 345: Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med (in press). 20 Das UN. Insulin and the critically ill. Crit Care 2002; 6: Wall RJ, Dittus RS, Ely EW. Protocol-driven care in the intensive care unit: a tool for quality. Crit Care 2001; 5:
Normal glucose values are associated with a lower risk of mortality in hospitalized patients
Diabetes Care Publish Ahead of Print, published online August Hyperglycemia 20, 2008 in hospital Normal glucose values are associated with a lower risk of mortality in hospitalized patients Alberto Bruno
More informationESPEN Congress Lisbon Water and electrolytes. Hyperglycemia management. G Van Den Berghe
ESPEN Congress Lisbon 2004 Water and electrolytes Hyperglycemia management G Van Den Berghe Intensive Insulin Therapy in ICU G. Van den Berghe M.D., Ph.D. Department of Intensive Care Medicine University
More informationHyperglycemia in ACS. Dr. Imhemed Eljazwi
Hyperglycemia in ACS 2012-5-8 Dr. Imhemed Eljazwi Percentage of Population (n = 1181) Prevalence of Hyperglycemia in 181 Cardiac Patients Without Known Diabetes 100% 75% 50% 66% of AMI patients have
More informationOutcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* Greet Van den Berghe, MD, PhD; Pieter J. Wouters, MSc; Roger Bouillon, MD, PhD; Frank Weekers,
More informationControl of Blood Glucose in the ICU: Reconciling the Conflicting Data
Control of Blood Glucose in the ICU: Reconciling the Conflicting Data Steven E. Nissen MD Disclosure Consulting: Many pharmaceutical companies Clinical Trials: AbbVie, Amgen, Astra Zeneca, Esperion, Eli
More informationHyperglycemia occurs frequently in critically ill patients.
Mayo Clin Proc, December 2003, Vol 78 Hyperglycemia and Increased Hospital Mortality 1471 Original Article Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population
More informationINTENSIVE INSULIN THERAPY: A Long History of Conflicting Data.
INTENSIVE INSULIN THERAPY: A Long History of Conflicting Data. Candice Preslaski, PharmD BCPS Clinical Pharmacist Specialist SICU Denver Health Medical Center December 2014 OBJECTIVES Review the risk factors
More informationUniversity of Groningen
University of Groningen Computer assisted decision support in acutely ill patients. Application in glucose management and quantification of myocardial reperfusion Vogelzang, Mathijs IMPORTANT NOTE: You
More informationInsulin therapy protects the central and peripheral nervous system of intensive care patients
protects the central and peripheral nervous system of intensive care patients G. Van den Berghe, MD, PhD; K. Schoonheydt, MD; P. Becx, MD; F. Bruyninckx, MD; and P.J. Wouters, MSc Abstract Objective: To
More information10.4.a. Optimal glucose control: Insulin therapy March 2013
10.4.a. Optimal glucose control: Insulin therapy March 2013 2013 Recommendation: Based on 26 level 2 studies, we recommend that hyperglycemia (blood sugars > 10 mmol/l) be avoided in all critically ill
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 Dysglycaemia In Acute Patients With Nutritional Therapy Mechanisms And Consequences Of Dysglycaemia In Patients Receiving Nutritional Therapy M. León- Sanz (ES) Mechanisms and
More informationThe effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review protocol
The effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review protocol Megan Higgs, BN, MN, PhD Candidate 1,3 Ritin Fernandez, BSc (Nursing),
More informationDeepika Reddy MD Department of Endocrinology
Deepika Reddy MD Department of Endocrinology Management of hyperglycemic crisis Review need for inpatient glycemic control Brief overview of relevant trials Case based review of diabetes management strategies/review
More informationVANDERBILT UNIVERSITY MEDICAL CENTER MULTIDISCIPLINARY SURGICAL CRITICAL CARE TRAUMA INTENSIVE CARE UNIT GLYCEMIC CONTROL PROTOCOL
VANDERBILT UNIVERSITY MEDICAL CENTER MULTIDISCIPLINARY SURGICAL CRITICAL CARE TRAUMA INTENSIVE CARE UNIT GLYCEMIC CONTROL PROTOCOL Background: For some time, the presence of diabetes and hyperglycemia
More informationC CONFERENCIAS MAGISTRALES Vol. 36. Supl. 1 Abril-Junio 2013 pp S61-S68 Management of hyperglycemia in the perioperative patient. 39 th Annual Refresher Course on Anesthesiology and Perioperative Medicine,
More informationACUTE ABDOMEN IN DIABETIC PATIENTS ANALYSIS OF COMPLICATIONS AND MORTALITY
2014 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(4):277-284 doi: 10.2478/rjdnmd-2014-0034 ACUTE ABDOMEN IN DIABETIC PATIENTS ANALYSIS OF COMPLICATIONS
More informationmagic DRAGONS: A Protocol for Accurate Glycaemic Control in General Wards
Preprints of the 19th World Congress The International Federation of Automatic Control magic DRAGONS: A Protocol for Accurate Glycaemic Control in General Wards Felicity Thomas,* Hamish Tomlinson,* Angus
More informationA Children s Bedtime Story
A Children s Bedtime Story Setting: University Medical Center, Big Town, USA Scenario: 0500, last admission of the night, 10 previous admissions, all tucked in for the night Patient: 75 year old male with
More informationParenterale voeding tijdens kritieke ziekte: bijkomende analyses van de EPaNIC studie
Parenterale voeding tijdens kritieke ziekte: bijkomende analyses van de EPaNIC studie Namens alle auteurs Michaël P. Casaer M.D. Department of Intensive Care Medicine University Hospital Gasthuisberg Catholic
More informationGLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS
GLYCEMIC CONTROL IN NEUROCRITICAL CARE PATIENTS David Zygun MD MSc FRCPC Professor and Director Division of Critical Care Medicine University of Alberta Zone Clinical Department Head Critical Care Medicine,
More informationIntensive Insulin Therapy in the Medical ICU. Abstract
The new england journal of medicine established in 1812 february 2, 2006 vol. 354 no. 5 Insulin Therapy in the Medical ICU Greet Van den Berghe, M.D., Ph.D., Alexander Wilmer, M.D., Ph.D., Greet Hermans,
More informationControversies in Hospital Medicine: Critical Care. Vasopressors, Steroids, and Insulin Therapy
Controversies in Hospital Medicine: Critical Care Vasopressors, Steroids, and Insulin Therapy Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado Denver Clinical Specialist in Critical
More informationInsulin reduces Neuromuscular Complications and Prolonged Mechanical Ventilation in a Medical ICU. Online data supplement
Insulin reduces Neuromuscular Complications and Prolonged Mechanical Ventilation in a Medical ICU Greet Hermans 1, Alexander Wilmer 1, Wouter Meersseman 1, Ilse Milants 2, Pieter J. Wouters 2, Herman Bobbaers
More informationDisclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures
Disclosures Glycemic Control in the Intensive Care Unit No disclosures Jorie Frasiolas, Pharm.D., BCPS Clinical Pharmacy Manager, CTICU NewYork-Presbyterian Hospital Columbia University Medical Center
More informationPaper reports. Overview Sepsis, insulin and noninvasive ventilation Richard Venn
Available online http://ccforum.com/content/6/1/093 Paper reports Synopses of recently published research relevant to intensivists 6 November 2001 8 January 2002 Overview Sepsis, insulin and noninvasive
More informationEU RISK MANAGEMENT PLAN (EU RMP) Nutriflex Omega peri emulsion for infusion , version 1.1
EU RISK MANAGEMENT PLAN (EU RMP) Nutriflex Omega peri emulsion for infusion 13.7.2015, version 1.1 III.1. Elements for a Public Summary III.1.1. Overview of disease epidemiology Patients may need parenteral
More informationParenteral Nutrition The Sweet and Sour Truth. From: Division of Endocrinology, Diabetes and Bone Disease Icahn School of Medicine at Mount Sinai
ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset
More informationEffect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
ORIGINAL ARTICLE GLUCOSE MANAGEMENT IN CRITICALLY ILL ADULT PATIENTS Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients JAMES STEPHEN KRINSLEY, MD OBJECTIVE:
More informationTherapeutic Effect of Insulin in Reducing Critical Illness; Polyneuropathy and Myopathy in the Pediatric Intensive Care Unit
original ARTICLE Therapeutic Effect of Insulin in Reducing Critical Illness; Polyneuropathy and Myopathy in the Pediatric Intensive Care Unit How to Cite this Article: Bilan N, Sadegvand, Ranjbar Sh. Therapeutic
More informationWhen to start SPN in critically ill patients? Refereeravond IC
When to start SPN in critically ill patients? Refereeravond IC Introduction (1) Protein/calorie malnutrition is very frequent in critically ill patients Protein/calorie malnutrition is associated with
More informationand ICU - an update Michal Horácek
Glycemic control in perioperative period and ICU - an update Michal Horácek 73 The three Leuwen studies (1-3), especially the first one published in 2001 (1), caused a revolution in the approach to glucose
More information123 Are You Providing Evidence-Based Diabetes Care? - Martin
Donna Martin, DNP, RN, CDE, CMSRN Lewis University Learner will be able to: Identify current inpatient standards of care for patients with diabetes Describe causes of hyperglycemia / hypoglycemia in the
More informationIn - Hospital Diabetes Care. A review and personal experience
In - Hospital Diabetes Care A review and personal experience Hyperglycemia in the Hospital The Problem Hospitalizations with Diabetes http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm Prevalence of
More informationKeywords critically ill patients, hyperglycaemia, normoglycaemia, outcome, prognosis
Critical Care June 2004 Vol 8 No 3 Vogelzang et al. Research Hyperglycaemic index as a tool to assess glucose control: a retrospective study Mathijs Vogelzang 1, Iwan CC van der Horst 2 and Maarten WN
More informationUpdate in Critical Care Medicine
Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright 001 by the Massachusetts Medical Society VOLUME 345 N OVEMBER 8, 001 NUMBER 1 INTENSIVE INSULIN THERAPY IN CRITICALLY ILL PATIENTS GREET VAN DEN BERGHE, M.D.,
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Gornik I., Vujaklija A., Lukić E., Madžarac G., Gašparović V. (00) Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus.
More informationEndocrine and Metabolic Complications in the ICU
Endocrine and Metabolic Complications in the ICU Linda Liu, M.D. Associate Professor UCSF Department of Anesthesia UC SF 1 New Progress Discovery of complex neuro-endocrine adaptation to critical illness
More information9 Diabetes care. Back to contents
Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are
More informationVijayaprasad Gopichandran, Shriraam Mahadevan, Latha Ravikumar, Gomathy Parasuraman, Anjali Sathya, Bhuma Srinivasan, Usha Sriram
Original Article Assessment of knowledge, attitudes and practices about tight glycemic control in the critically ill among endocrinologists and intensivists practicing in Chennai Vijayaprasad Gopichandran,
More informationImpact of admission hyperglycemia on hospital mortality in various intensive care unit populations*
Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations* Brian W. Whitcomb, BA; Elizabeth Kimbrough Pradhan, MS; Anastassios G. Pittas, MD; Mary-Claire Roghmann,
More informationDiabetes in obstetric patients
Diabetes in obstetric patients Swedish Society of Obstetric Anaesthesia & Intensive Care Anita Banerjee Obstetric Physician Diabetes & Endocrinology Consultant Outline Scope of the problem Diabetes and
More informationInflammation. Sepsis Ladder
Maureen Maloney-Poldek MSN, RN Chamberlain College of Nursing Pathophysiology of sepsis and septic shock How sepsis affects the endocrine system Pathophysiology of adrenal insufficiency Clinical manifestations
More informationDiabetes Care 29: , 2006
Clinical Care/Education/Nutrtion O R I G I N A L A R T I C L E The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study A randomized controlled trial of insulin infusion therapy for myocardial
More informationSurviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality
More informationWhat Should Be the Therapeutic Glycemic Target in Intensive Care Units?
What Should Be the Therapeutic Glycemic Target in Intensive Care Units? Irl B. Hirsch, M.D. Professor of Medicine University of Washington School of Medicine Disclosures Research/Grants: Sanofi, Halozyme
More informationInternational Journal of Surgery
International Journal of Surgery 8 (200) 494e498 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.theijs.com Peri-operative blood glucose management in general
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationIs Intense Glycemic Control Really Better?
University of Wyoming Wyoming Scholars Repository Honors Theses AY 16/17 Undergraduate Honors Theses Spring 5-12-2017 Is Intense Glycemic Control Really Better? Cierra W. Schutzman University of Wyoming,
More informationMANAGEMENT OF HYPERGLYCEMIA IN CRITICALLY ILL SURGICAL (NON-CARDIAC) PATIENTS
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationBIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency
BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency Medicine 1 NO CONFLICT OF INTEREST 2 We do not fully understand
More informationTight Glucose Control in Sepsis
Tight Glucose Control in Sepsis Dr. Pedro Celiny Ramos Garcia UTI Pediátrica Hospital São Lucas - Faculdade de Medicina Pontifícia Universidade Católica do RS - Brasil 1 Porto o Alegre, Brasil Spanish
More informationBack to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
More informationMODERN CRITICAL CARE IS
CARING FOR THE CRITICALLY ILL ATIENT Glucose Control and Mortality in Critically Ill atients Simon J. Finney, MBChB, MRC Cornelia Zekveld, BSc (Hons), MSc Andi Elia, BSc Timothy W. Evans, MD, DSc, FRC
More informationSubclinical Problems in the ICU:
Subclinical Problems in the ICU: Corticosteroid Insufficiency C. S. Cutillar, M.D., FPCP, FPSEM Associate Professor Cebu Institute of Medicine H-P-A Axis during Critical Illness CRH ACTH H-P-A Axis during
More informationHarm by hyperglycemia, early (parenteral) nutrition or both? from bed to bench and back
Harm by hyperglycemia, early (parenteral) nutrition or both? from bed to bench and back G. Van den Berghe MD, PhD Department of Intensive Care Medicine University of Leuven (KU Leuven) Leuven, Belgium
More informationFINANCIAL IMPLICATIONS OF GLYCEMIC CONTROL: RESULTS OF AN INPATIENT DIABETES MANAGEMENT PROGRAM
ACE/ADA Inpatient Diabetes and Glycemic Control Consensus Conference FINANCIAL IMPLICATIONS OF GLYCEMIC CONTROL: RESULTS OF AN INPATIENT DIABETES MANAGEMENT PROGRAM Christopher A. Newton, MD, 1 and Sandra
More informationAlarge, randomized, controlled trial
Emerging Treatments and Technologies O R I G I N A L A R T I C L E Glucommander A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation PAUL C.
More informationJournal Club ICU
Journal Club 2018.9.4 ICU Crit Care Med. 2018 Aug;46(8):1224-1229 Introduction Stress hyperglycemia SH SH >124 mg/dl or >200 mg/dl Lancet 2009;373:1798. stress hyperglycemia Lancet 2009;373:1798. SH Critical
More informationOutcomes and Perioperative Hyperglycemia in Patients With or Without Diabetes Mellitus Undergoing Coronary Artery Bypass Grafting
CARDIOVASCULAR Outcomes and Perioperative Hyperglycemia in Patients With or Without Diabetes Mellitus Undergoing Coronary Artery Bypass Grafting Carlos A. Estrada, MD, MS, James A. Young, MD, L. Wiley
More informationISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)
Contact Details Name: Hospital Telephone: This protocol has 5 pages ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version) Please read carefully. Meticulous treatment is very important as there
More information[No conflicts of interest]
[No conflicts of interest] Patients and staff at: Available evidence pre-calories Three meta-analyses: Gramlich L et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes
More informationFluid and electrolyte therapies including nutritional support are markedly developing in medicine
J Korean Med Assoc 2010 December; 53(12): 1103-1112 DOI: 10.5124/jkma.2010.53.12.1103 pissn: 1975-8456 eissn: 2093-5951 http://jkma.org Continuing Education Column Fluid therapy: classification and characteristics
More informationIMPROVEMENT OF GLUCOSE CONTROL IN THE INTENSIVE CARE UNIT: AN INTERDISCIPLINARY COLLABORATION STUDY. Patient Safety Issues
Patient Safety Issues IMPROVEMENT OF GLUCOSE CONTROL IN THE INTENSIVE CARE UNIT: AN INTERDISCIPLINARY COLLABORATION STUDY By Ulrike Holzinger, MD, Monika Feldbacher, RN, Adelbert Bachlechner, RN, Reinhard
More informationManagement of cardiovascular disease. Acute coronary syndromes and intensive care. Lars Rydén Karolinska Institutet Stockholm, Sweden
Management of cardiovascular disease Acute coronary syndromes and intensive care Lars Rydén Karolinska Institutet Stockholm, Sweden Hyperglycemia and acute coronary syndromes Changing fenotype GAMI Study
More informationThe Portland Diabetic Project: Hyperglycemia/Mortality Hypothesis
The Portland Diabetic Project: Hyperglycemia/Mortality Hypothesis Perioperative Hyperglycemia increases the risk of mortality in patients undergoing CABG. (n = 3956) 6.1% 4.9% The Portland Diabetic Project
More informationPeri-operative Glucose Control Is it Important?
Peri-operative Glucose Control Is it Important? Dr Ketan Dhatariya MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich University Hospitals Do Peri-Operative High Glucose Levels
More informationDELIRIUM IN ICU: Prevention and Management. Milind Baldi
DELIRIUM IN ICU: Prevention and Management Milind Baldi Contents Introduction Risk factors Assessment Prevention Management Introduction Delirium is a syndrome characterized by acute cerebral dysfunction
More informationBrain dysfunction in the ICU
High cortisol levels are associated with brain dysfunction but low prolactin cortisol ratio levels are associated with nosocomial infection in severe sepsis Duc Nam Nguyen Luc Huyghens Johan Schiettecatte
More informationHAP PA-HEN Achieving More Together
HAP PA-HEN Achieving More Together Managing Hyperglycemia in the Hospital: Strategies for Safe and Effective Care Pennsylvania Patient Safety Authority Managing Hyperglycemia in the Hospital: Strategies
More informationAcute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
More informationCase study: Individual with inadequate glycaemic control due to poor adherence to medication
Case study: Individual with inadequate glycaemic control due to poor adherence to medication Authored by Linong Ji and Clifford Bailey on behalf of the Global Partnership for Effective Diabetes Management.
More informationBy; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital
By; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital Introduction The significance of nutrition in hospital setting (especially the ICU) cannot be overstated.
More informationSupplement Table 1. Definitions for Causes of Death
Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death
More informationEpidemiological studies have revealed
Emerging Treatments and Technologies O R I G I N A L A R T I C L E Multicentric, Randomized, Controlled Trial to Evaluate Blood Glucose Control by the Model Predictive Control Algorithm Versus Routine
More informationSupplemental Information
FROM THE AMERICAN ACADEMY OF PEDIATRICS Supplemental Information SUPPLEMENTAL FIGURE 2 Forest plot of all included RCTs using a random-effects model and M-H statistics with the outcome of hyponatremia
More informationEvidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
More informationCritical Illness Neuropathy
Critical Illness Neuropathy JILL McEWEN, MD FRCPC Clinical Professor & Director Undergraduate Education Program Department of Emergency Medicine University of British Columbia Vancouver, BC Canada Immediate
More informationARELATIONSHIP between admission plasma glucose
0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(3):978 982 Printed in U.S.A. Copyright 2002 by The Endocrine Society Hyperglycemia: An Independent Marker of In-Hospital Mortality
More informationCritical care resources are often provided to the too well and as well as. to the too sick. The former include the patients admitted to an ICU
Literature Review Critical care resources are often provided to the too well and as well as to the too sick. The former include the patients admitted to an ICU following major elective surgery for overnight
More informationType of intervention Treatment and secondary prevention. Economic study type Cost-effectiveness analysis.
Cost effectiveness in the treatment of heart failure with ramipril: a Swedish substudy of the AIRE study Erhardt L, Ball S, Andersson F, Bergentoft P, Martinez C. Record Status This is a critical abstract
More informationThe effects of hyperglycemia on length of stay with myocardial infarction
The effects of hyperglycemia on length of stay with myocardial infarction By: Jenny P. Simpson and Patricia B. Crane Simpson, J., & Crane, P.B. (2005). The effects of hyperglycemia on length of stay with
More informationGlycemic control a matter of life and death
Glycemic control a matter of life and death Linda Garcia Mellbin MD PhD Specialist in Cardiology & Internal medicine Dep of Cardiology Karolinska University Hospital /Karolinska Institutet Mortality (%)
More informationWhy is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationTargeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study
Targeting Glucose Metabolism to Stop Strokes IRIS: Insulin Resistance In Stroke study Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford
More informationGlycemic Control Insulin In The Hospital Setting
Glycemic Control Insulin In The Hospital Setting Glycemic Control The Evidence For Insulin s s Benefit The Mechanism of Insulin s s Benefit The Achievement of Insulin s s Benefit A Few Cases Hyperglycemia
More informationA factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Hypotheses: Among individuals with type 2 diabetes, the risks of major microvascular
More informationSafety and Effectiveness of a Computerized Subcutaneous Insulin Program to Treat Inpatient Hyperglycemia
Journal of Diabetes Science and Technology Volume 2, Issue 3, May 2008 Diabetes Technology Society SYMPOSIUM Safety and Effectiveness of a Computerized Subcutaneous Insulin Program to Treat Inpatient Hyperglycemia
More informationMartin J Stevens MD, FRCP, Endocrinologist and Professor of Medicine
The Approach to Inpatient Hyperglycemia Martin J Stevens MD, FRCP, Endocrinologist and Professor of Medicine Great Lakes Hospital Medical Symposium May 7th 2010 Further Increases in the Prevalence of Diabetes
More informationOklahoma Dietetic Association. Ainsley Malone, MS, RD, LD, CNSD April, 16, 2008 Permissive Underfeeding: What, Where and Why? Mt.
The What, Why and When of Permissive Ainsley Malone, MS, RD, CNSD Nutrition Support Team Mt. Carmel West Hospital Mt. Carmel West 500 bed academic center Non-physician based NST Dietitian, pharmacist and
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Using the gut in acute care patients Permissive underfeeding in practice J.-C. Preiser (BE) PERMISSIVE UNDERFEEDING IN PRACTICE ESPEN congress Jean-Charles Preiser, M.D.,
More informationWhat is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14
What is the Role of Albumin in Sepsis? An Evidenced Based Affair Justin Belsky MD PGY3 2/6/14 Microcirculation https://www.youtube.com/watch?v=xao1gsyur7q Capillary Leak in Sepsis Asking the RIGHT Question
More informationNutrients, insulin and muscle wasting during critical illness
32 nd annual meeting of the Belgian Society of Intensive Care Medicine June 15, 212 Nutrients, insulin and muscle wasting during critical illness Sarah Derde Introduction Critical illness: feeding-resistant
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationRelationship between glucose meter error and glycemic control efficacy
Relationship between glucose meter error and glycemic control efficacy Brad S. Karon, M.D., Ph.D. Professor of Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology Mayo Clinic
More informationKey Points. Angus DC: Crit Care Med 29:1303, 2001
Sepsis Key Points Sepsis is the combination of a known or suspected infection and an accompanying systemic inflammatory response (SIRS) Severe sepsis is sepsis with acute dysfunction of one or more organ
More information